Kilitch Drugs (India) Limited (BOM:524500)
India · Delayed Price · Currency is INR 317.30
-1.90 (-0.60%)
At close: Jan 22, 2026
Kilitch Drugs (India) Revenue
Kilitch Drugs (India) had revenue of 489.25M INR in the quarter ending September 30, 2025, with 3.05% growth. This brings the company's revenue in the last twelve months to 2.09B, up 32.95% year-over-year. In the fiscal year ending March 31, 2025, Kilitch Drugs (India) had annual revenue of 1.98B with 28.47% growth.
Revenue (ttm)
2.09B
Revenue Growth
+32.95%
P/S Ratio
2.44
Revenue / Employee
11.20M
Employees
187
Market Cap
5.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.98B | 439.46M | 28.47% |
| Mar 31, 2024 | 1.54B | 147.74M | 10.58% |
| Mar 31, 2023 | 1.40B | 253.65M | 22.20% |
| Mar 31, 2022 | 1.14B | 457.11M | 66.71% |
| Mar 31, 2021 | 685.23M | 152.03M | 28.51% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anuh Pharma | 7.30B |
| Wanbury | 6.31B |
| Sudarshan Pharma Industries | 5.92B |
| Kopran | 5.92B |
| Fredun Pharmaceuticals | 5.31B |
| Albert David | 3.16B |
| Accent Microcell | 2.78B |
| Everest Organics | 1.89B |
Kilitch Drugs (India) News
- 1 year ago - Kilitch Drugs India shares surge over 2% as company invests $200,000 in Kilitch Estro Biotech - Business Upturn